Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELUW) Other Non Operating Income (2020 - 2025)

Historic Other Non Operating Income for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to -$620000.0.

  • Celularity's Other Non Operating Income fell 90519.48% to -$620000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.3 million, marking a year-over-year decrease of 10551.95%. This contributed to the annual value of -$3.9 million for FY2024, which is 10331.18% down from last year.
  • Latest data reveals that Celularity reported Other Non Operating Income of -$620000.0 as of Q3 2025, which was down 90519.48% from $62000.0 recorded in Q2 2025.
  • In the past 5 years, Celularity's Other Non Operating Income registered a high of $117.8 million during Q4 2023, and its lowest value of -$5.7 million during Q1 2025.
  • Its 5-year average for Other Non Operating Income is $6.0 million, with a median of $64000.0 in 2023.
  • As far as peak fluctuations go, Celularity's Other Non Operating Income surged by 5599333.33% in 2023, and later tumbled by 346896.55% in 2024.
  • Over the past 5 years, Celularity's Other Non Operating Income (Quarter) stood at $8000.0 in 2021, then soared by 2525.0% to $210000.0 in 2022, then skyrocketed by 55993.33% to $117.8 million in 2023, then tumbled by 99.93% to $77000.0 in 2024, then tumbled by 905.19% to -$620000.0 in 2025.
  • Its Other Non Operating Income stands at -$620000.0 for Q3 2025, versus $62000.0 for Q2 2025 and -$5.7 million for Q1 2025.